COLLECT: Comparison of Different Methods for the Analysis of Gut Microbiome Composition

Sponsor
Charite University, Berlin, Germany (Other)
Overall Status
Completed
CT.gov ID
NCT04082221
Collaborator
(none)
28
1
5.8
4.8

Study Details

Study Description

Brief Summary

The human gastrointestinal tract shelters a complex and dynamic population of microorganisms, the gut microbiota, which plays an important role in immune and metabolic homeostasis. In recent years several major diseases were linked with alterations in the gut microbiome composition.

There are known factors which can influence gut microbiata composition. For example diet is known to play a fundamental role in determining the composition of the intestinal microbiota over time. However, there are very few studies evaluating how collection and DNA isolation methods affect microbiome composition.

Condition or Disease Intervention/Treatment Phase
  • Other: no intervention

Detailed Description

An observational clinical study with 28 healthy subjects is planned to assess how different commercially available stool sampling kits and fecal DNA extraction kits influence the apparent composition of the gut microbiome. Participants will be instructed to collect stool samples at two time points separated by one week using six different methods (naïve and Zymo DNA/RNA Shield kit on dry ice as well as OMNIgene GUT, RNALater, 95% EtOH, Zymo DNA/RNA Shield at room temperature). DNA extraction from all samples will be performed using QIAamp Power Fecal (Qiagen, N. V) and ZymoBIOMICS (Zymo Research, CA.).

Study Design

Study Type:
Observational
Actual Enrollment :
28 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
The Influence of Different Sample Collection and DNA Extraction Methods on the Bacterial Composition of the Gut of Healthy Subjects
Actual Study Start Date :
Mar 11, 2019
Actual Primary Completion Date :
Jun 30, 2019
Actual Study Completion Date :
Sep 5, 2019

Outcome Measures

Primary Outcome Measures

  1. Collection of stool samples [one week]

    Collection of 2 stool samples in one week using different conditions DNA extraction from all samples will be performed using QIAamp Power Fecal (Qiagen, N. V) and ZymoBIOMICS (Zymo Research, CA.) to assess how different commercially available stool sampling kits and fecal DNA extraction kits influence the apparent composition of the gut microbiome

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Age between 18-60

  • Body mass index (BMI) 18,5- 29,9 kg/m2

  • Willingness to participate in the study examination and fecal sample collection process

Exclusion Criteria:
  • Subjects currently on medication (with the exception of contraceptives)

  • Subjects with acute or chronic disease

  • Pregnant or lactating women

  • Subjects with a history of drug or alcohol abuse

  • Subjects on a vegan diet

  • Subjects who are legal incapacitated or their circumstances do not enable the patient to fully understand the nature, significance and scope of this study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Experimental and Clinical Research Center, Clinical Research Unit Berlin Germany 13125

Sponsors and Collaborators

  • Charite University, Berlin, Germany

Investigators

  • Study Chair: Anja Mähler, PhD, Franz-Volhard-Centr. at the Experimental and Clinicial Research Center

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Dr. Lajos Marko, Principal Investigator, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT04082221
Other Study ID Numbers:
  • ChariteU-ECRC-COLLECT
First Posted:
Sep 9, 2019
Last Update Posted:
Sep 11, 2019
Last Verified:
Sep 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Sep 11, 2019